1 MCQs in Microbiology for NEET PG
A 35-year-old man with newly diagnosed pulmonary tuberculosis is started on standard 4-drug therapy including isoniazid. He is a slow acetylator of isoniazid (genetic polymorphism in N-acetyltransferase). The structure marked **A** in the diagram is the target of isoniazid action. Which of the following adverse effects is this patient at HIGHEST risk of developing due to his slow acetylator phenotype?
Ready to test yourself?
Test your Microbiology knowledge with AI-powered MCQs and detailed explanations — no signup required to try.
Sign up free and practice all 1 Mycobacterium tuberculosis — Cell Wall and Drug Targets MCQs with AI-powered explanations tailored to your performance.
Create Free Account